TNF-α modulates the immunosuppressive effects of MSCs on dendritic cells and T cells

International Immunopharmacology

Volumn 28, Issue 2, 2015, Pages 1009-1017

  Mohammadpour, Hemn ^a   Pourfathollah, Ali Akbar ^a   Zarif, Mahin Nikougoftar ^b   Tahoori, Mohammad Taher ^c  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

^c SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dendritic cells; IDO; IFN ; Mesenchymal stem cells; T cells; TNF

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; CELL SURFACE MARKER; GAMMA INTERFERON; HLA DR ANTIGEN; ICOSL PROTEIN; INDOLEAMINE 2,3 DEOXYGENASE; OXYGENASE; PDL1 PROTEIN; PDL2 PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CYTOKINE; INDOLEAMINE 2,3 DIOXYGENASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL POLARITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; IMMUNE SYSTEM; IMMUNOMODULATION; LYMPHOCYTE SUBPOPULATION; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CELL DIFFERENTIATION; COCULTURE; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MESENCHYMAL STROMA CELL; METABOLISM; PARACRINE SIGNALING; TUMOR MICROENVIRONMENT;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CELLULAR MICROENVIRONMENT; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; FEMALE; HLA-DR ANTIGENS; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LYMPHOCYTE ACTIVATION; MESENCHYMAL STROMAL CELLS; MICE, INBRED BALB C; PARACRINE COMMUNICATION; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84979180117     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.07.045     Document Type: Article

References (26)

1. [1] Banchereau, J., Steinman, R.M., Dendritic cells and the control of immunity. Nature 392 (1998), 245–252.
2. [2] Palucka, A.K., Laupeze, B., Aspord, C., Saito, H., Jego, G., Fay, J., et al. Immunotherapy Via Dendritic Cells. Mechanisms Of Lymphocyte Activation And Immune Regulation X. 2005, Springer, 105–114.
3. [3] Lutz, M.B., Schuler, G., Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol. 23 (2002), 445–449.
4. [4] Lanzavecchia, A., Sallusto, F., Regulation of T cell immunity by dendritic cells. Cell 106 (2001), 263–266.
5. [5] Jiang, X.-X., Zhang, Y., Liu, B., Zhang, S.-X., Wu, Y., Yu, X.-D., et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105 (2005), 4120–4126.
6. [6] Nauta, A.J., Kruisselbrink, A.B., Lurvink, E., Willemze, R., Fibbe, W.E., Mesenchymal stem cells inhibit generation and function of both CD34 +-derived and monocyte-derived dendritic cells. J. Immunol. 177 (2006), 2080–2087.
7. [7] Uccelli, A., Moretta, L., Pistoia, V., Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8 (2008), 726–736.
8. [8] Houthuijzen, J., Daenen, L., Roodhart, J., Voest, E., The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression. Br. J. Cancer 106 (2012), 1901–1906.
9. [9] Stagg, J., Immune regulation by mesenchymal stem cells: two sides to the coin. Tissue Antigens 69 (2007), 1–9.
10. [10] Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P.D., Matteucci, P., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99 (2002), 3838–3843.
11. [11] Djouad, F., Charbonnier, L.M., Bouffi, C., Louis‐Plence, P., Bony, C., Apparailly, F., et al. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin‐6‐dependent mechanism. Stem Cells 25 (2007), 2025–2032.
12. [12] English, K., Barry, F.P., Field-Corbett, C.P., Mahon, B.P., IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells. Immunol. Lett. 110 (2007), 91–100.
13. [13] Lee, R.H., Yoon, N., Reneau, J.C., Prockop, D.J., Preactivation of human MSCs with TNF-α enhances tumor-suppressive activity. Cell 11 (2012), 825–835.
14. [14] Fu, X., Han, B., Cai, S., Lei, Y., Sun, T., Sheng, Z., Migration of bone marrow‐derived mesenchymal stem cells induced by tumor necrosis factor‐α and its possible role in wound healing. Wound Repair Regen. 17 (2009), 185–191.
15. [15] Sung, J., Yang, H.-M., Park, J., Choi, G.-S., Joh, J.-W., Kwon, C., et al. Isolation and characterization of mouse mesenchymal stem cells. Transplantation proceedings, 2008, Elsevier, 2649–2654.
16. [16] Zheng, X., Koropatnick, J., Li, M., Zhang, X., Ling, F., Ren, X., et al. Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference. J. Immunol. 177 (2006), 5639–5646.
17. [17] Zhang, W., Ge, W., Li, C., You, S., Liao, L., Han, Q., et al. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev. 13 (2004), 263–271.
18. [18] Aggarwal, S., Pittenger, M.F., Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (2005), 1815–1822.
19. [19] Hemeda, H., Jakob, M., Ludwig, A.-K., Giebel, B., Lang, S., Brandau, S., Interferon-γ and tumor necrosis factor-α differentially affect cytokine expression and migration properties of mesenchymal stem cells. Stem Cells Dev. 19 (2010), 693–706.
20. [20] Spaggiari, G.M., Abdelrazik, H., Becchetti, F., Moretta, L., MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113 (2009), 6576–6583.
21. [21] Trabanelli, S., Lecciso, M., Salvestrini, V., Cavo, M., Očadlíková, D., Lemoli, R.M., et al. PGE 2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response. J. Immunol. Res., 2015, 2015.
22. [22] Pallotta, M.T., Orabona, C., Volpi, C., Vacca, C., Belladonna, M.L., Bianchi, R., et al. Indoleamine 2, 3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat. Immunol. 12 (2011), 870–878.
23. [23] Chen, H.-W., Chen, H.-Y., Wang, L.-T., Wang, F.-H., Fang, L.-W., Lai, H.-Y., et al. Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines. J. Immunol. 190 (2013), 5065–5077.
24. [24] Zhang, Z., Han, Y., Song, J., Luo, R., Jin, X., Mu, D., et al. Interferon‐γ regulates the function of mesenchymal stem cells from oral lichen planus via indoleamine 2, 3‐dioxygenase activity. J. Oral Pathol. Med. 44 (2015), 15–27.
25. [25] Larocca, R.A., Moraes-Vieira, P.M., Bassi, Ê.J., Semedo, P., de Almeida, D.C., da Silva, M.B., et al. Adipose tissue-derived mesenchymal stem cells increase skin allograft survival and inhibit Th-17 immune response. PLoS One, 8, 2013, e76396.
26. [26] Pianta, S., Signoroni, P.B., Muradore, I., Rodrigues, M.F., Rossi, D., Silini, A., et al. Amniotic membrane mesenchymal cells-derived factors skew T cell polarization toward Treg and downregulate Th1 and Th17 cells subsets. Stem Cell Rev., 1–14, 2014.